OXiGENE, Inc.
26Patents
5Active
26Granted
34Portfolio score
Filing activity: Oct 22, 1990 → Feb 13, 2014 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6538038B1 | Compositions and methods for use in targeting vascular destruction | Human Necessities | 35 | Expired |
| US6020351A | Carotenoid-nicotinamide-zinc compositions and methods of treatment using same | Human Necessities | 18 | Expired |
| US5204241A | Glutathione-S-transferase mu as a measure of drug resistance | Physics | 10 | Expired |
| US6339073B1 | Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases | Chemistry; Metallurgy | 9 | Expired |
| US6919324B2 | Functionalized stilbene derivatives as improved vascular targeting agents | Chemistry; Metallurgy | 9 | Expired |
| US5340565A | Tumor or cancer cell killing therapy and agents useful therefor | Human Necessities | 6 | Expired |
| US7037906B1 | Methods for modulating tumor growth and metastasis | Human Necessities | 4 | Expired |
| US7358236B1 | Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents | Human Necessities | 4 | Expired |
| US6028111A | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents | Chemistry; Metallurgy | 3 | Expired |
| US6100299A | N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use | Human Necessities | 3 | Expired |
| US8198302B2 | Compositions and methods with enhanced therapeutic activity | Chemistry; Metallurgy | 2 | Active |
| US8877967B2 | Compositions and methods for inhibition of cathepsins | Chemistry; Metallurgy | 2 | Active |
| US5561129A | Methods of administering phenothiazines and/or acid addition salts thereof | Human Necessities | 2 | Expired |
| US6773702B2 | Use of combretastatin A4 and its prodrugs as an immune enhancing therapy | Human Necessities | 2 | Expired |
| US5561161A | Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof | Human Necessities | 2 | Expired |
| US7456214B2 | Chromene-containing compounds with anti-tubulin and vascular targeting activity | Human Necessities | 1 | Expired |
| US7384925B2 | Functionalized stilbene derivatives as improved vascular targeting agents | Chemistry; Metallurgy | 1 | Expired |
| US7091240B2 | Tubulin binding ligands and corresponding prodrug constructs | Chemistry; Metallurgy | 1 | Expired |
| US6956054B2 | Compositions and methods for use in targeting vascular destruction | Human Necessities | 1 | Expired |
| US9040500B2 | Method for treating hematopoietic neoplasms | Human Necessities | 1 | Active |
| US7001926B2 | Tubulin binding agents and corresponding prodrug constructs | Chemistry; Metallurgy | 1 | Expired |
| US6743937B2 | Efficient method of synthesizing combretastatin A-4 prodrugs | Emerging Cross-Sectional Technologies | 1 | Expired |
| USRE45720E1 | Functionalized stilbene derivatives as improved vascular targeting agents | General | 0 | Active |
| US5925571A | Method of testing immune competency | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6713517B1 | Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.